These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10991934)

  • 1. Low doses of 8-OH-DPAT prevent the impairment of spatial learning caused by intrahippocampal scopolamine through 5-HT(1A) receptors in the dorsal raphe.
    Carli M; Balducci C; Samanin R
    Br J Pharmacol; 2000 Sep; 131(2):375-81. PubMed ID: 10991934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of 5-HT1A receptors in the dorsal raphe reverses the impairment of spatial learning caused by intrahippocampal scopolamine in rats.
    Carli M; Bonalumi P; Samanin R
    Eur J Neurosci; 1998 Jan; 10(1):221-30. PubMed ID: 9753130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of 5-HT(1A) receptors in the dorsal raphe ameliorates the impairment of spatial learning caused by intrahippocampal 7-chloro-kynurenic acid in naive and pretrained rats.
    Carli M; Balducci C; Samanin R
    Psychopharmacology (Berl); 2001 Oct; 158(1):39-47. PubMed ID: 11685382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine.
    Carli M; Balducci C; Millan MJ; Bonalumi P; Samanin R
    Br J Pharmacol; 1999 Nov; 128(6):1207-14. PubMed ID: 10578133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model.
    Cervo L; Mocaër E; Bertaglia A; Samanin R
    Neuropharmacology; 2000 Apr; 39(6):1037-43. PubMed ID: 10727714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.
    Carli M; Samanin R
    Psychopharmacology (Berl); 2000 Apr; 149(3):259-68. PubMed ID: 10823407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors).
    Riad M; Watkins KC; Doucet E; Hamon M; Descarries L
    J Neurosci; 2001 Nov; 21(21):8378-86. PubMed ID: 11606626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice.
    Stiedl O; Misane I; Spiess J; Ogren SO
    J Neurosci; 2000 Nov; 20(22):8515-27. PubMed ID: 11069959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo.
    Yoshitake T; Yoshitake S; Yamaguchi M; Ogren SO; Kehr J
    Neuropharmacology; 2003 Feb; 44(2):206-13. PubMed ID: 12623219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid.
    Carli M; Bonalumi P; Samanin R
    Brain Res; 1997 Nov; 774(1-2):167-74. PubMed ID: 9452205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors.
    Harrison AA; Markou A
    J Pharmacol Exp Ther; 2001 Apr; 297(1):316-25. PubMed ID: 11259559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral 8-OH-DPAT and scopolamine infused into the frontal cortex produce passive avoidance retention impairments in rats.
    Santucci AC; Shaw C
    Neurobiol Learn Mem; 2003 Mar; 79(2):136-41. PubMed ID: 12591222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by blockade of hippocampal NMDA receptors.
    Carli M; Silva S; Balducci C; Samanin R
    Neuropharmacology; 1999 Aug; 38(8):1165-73. PubMed ID: 10462129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; De Montigny C; Blier P
    Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial memory deficits following stimulation of hippocampal 5-HT1B receptors in the rat.
    Buhot MC; Patra SK; Naïli S
    Eur J Pharmacol; 1995 Oct; 285(3):221-8. PubMed ID: 8575507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E; Li H; Carr KD; Hiller JM
    J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (S)-WAY 100135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine.
    Carli M; Luschi R; Samanin R
    Eur J Pharmacol; 1995 Sep; 283(1-3):133-9. PubMed ID: 7498302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P
    Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
    Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
    Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.